Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glycemia control and choice of antihyperglycemic therapy in patients with type 2 diabetes mellitus and COVID-19: a consensus decision of the board of experts of the Russian association of endocrinologists
И. И. Дедов, Н. Г. Мокрышева, М. В. Шестакова, et al.
Diabetes Mellitus (2022) Vol. 25, Iss. 1, pp. 27-49
Open Access | Times Cited: 19

Showing 19 citing articles:

Organization of outpatient care for patients with diabetes mellitus in the context of the COVID-19 pandemic using telemedicine technologies
V. V. Chichkova, Marina Shapovalova, M. A. Chichkova, et al.
Diabetes Mellitus (2023) Vol. 26, Iss. 4, pp. 334-342
Open Access | Times Cited: 19
Analysis of risk factors for COVID-19-related fatal outcome in 337991 patients with type 1 and type 2 diabetes mellitus in 2020–2022 years: Russian nationwide retrospective study
Н. Г. Мокрышева, М. В. Шестакова, Olga Konstantinovna Vikulova, et al.
Diabetes Mellitus (2022) Vol. 25, Iss. 5, pp. 404-417
Open Access | Times Cited: 13
The impact of innovative glucose-lowering drugs on the course and outcome of COVID-19 in patients with type 2 diabetes mellitus
Т. Н. Маркова, M. Stas
Diabetes Mellitus (2024) Vol. 27, Iss. 2, pp. 174-184
Open Access | Times Cited: 1
The impact of carbohydrate metabolism disorders on the early and long-term clinical outcomes of patients with COVID-19 according to the AKTIV and AKTIV 2 registries
В. В. Салухов, G. P. Arutyunov, E. I. Tarlovskaya, et al.
Problems of Endocrinology (2023) Vol. 69, Iss. 1, pp. 36-49
Open Access | Times Cited: 4
Results of a 12-month follow-up of patients with type 2 diabetes mellitus after hospitalization with COVID-19: gliclazide MR use in the hospital and metabolic status at the posthospital stage
Т. А. Некрасова, Л. Г. Стронгин, D. V. Belikina, et al.
Diabetes Mellitus (2023) Vol. 26, Iss. 3, pp. 252-261
Open Access | Times Cited: 2
Metformin as an activator of AMP-activated protein kinase. Known and new mechanisms of action
А. M. Mkrtumyan, Т. Н. Маркова, M. A. Ovchinnikova, et al.
Diabetes Mellitus (2023) Vol. 26, Iss. 6, pp. 585-595
Open Access | Times Cited: 2
The therapeutic potential of the use of gliclazide MV in combination with COVID-19 and type 2 diabetes mellitus
D. V. Belikina, Т. А. Некрасова, Л. Г. Стронгин, et al.
FOCUS Endocrinology (2024) Vol. 5, Iss. 1, pp. 20-23
Open Access
Procalcitonin in new coronavirus infection (COVID-19), complicated by pneumonia, sepsis, in patients with diabetes mellitus
Е. А. Титова, Т. А. Лысенко, A. G. Koblov
Clinical Medicine (Russian Journal) (2024) Vol. 102, Iss. 7, pp. 523-528
Open Access
Сarbohydrate metabolism disorders and their outcomes in the long-term period in hospitalized patients with COVID-19
В. В. Салухов, А. А. Минаков, Tatyana G. Sharypova, et al.
Diabetes Mellitus (2022) Vol. 25, Iss. 5, pp. 468-476
Open Access | Times Cited: 3
The therapeutic potential of the use of gliclazide MV in combination with COVID-19 and type 2 diabetes mellitus
D. V. Belikina, Т. А. Некрасова, Л. Г. Стронгин, et al.
FOCUS Endocrinology (2024) Vol. 5, Iss. 1, pp. 20-23
Open Access
Diabetes-associated factors in hospitalized COVID-19 patients with concomitant type 2 diabetes mellitus: focus on mean in-hospital glycemic values
Diana Belkina, Т. А. Некрасова, Л. Г. Стронгин, et al.
FOCUS Endocrinology (2024) Vol. 5, Iss. 2, pp. 20-24
Open Access
Features of the course of COVID-19 in patients with type 2 diabetes mellitus
Е.А. Карасева, В. А. Мартынов, Т. Е. Филатова, et al.
Terapevticheskii arkhiv (2023) Vol. 95, Iss. 11, pp. 913-918
Open Access | Times Cited: 1
Efficacy and safety of glucagon-like peptide-1 receptor agonists therapy initiation in patients with type 2 diabetes hospitalized with coronavirus infection
Т. Н. Маркова, М. А. Лысенко, M. Stas, et al.
Diabetes Mellitus (2023) Vol. 26, Iss. 6, pp. 537-548
Open Access | Times Cited: 1
The prevalence of carbohydrate metabolism disorders in patients after coronavirus infection
Т. Н. Маркова, Anastasia A. Anchutina, Valeria Yu. Garib, et al.
City Healthcare (2022) Vol. 3, Iss. 4, pp. 32-41
Open Access | Times Cited: 2
DEVELOPMENT OF MICROCAPSULES BASED ON COMBINED ANTIDIABETIC SUBSTANCE: PHARMACOLOGICAL CHARACTERISTICS
A. Giyoszoda, Э. Ф. Степанова, О.Ф. Веселова, et al.
Pharmacy & Pharmacology (2022) Vol. 10, Iss. 4, pp. 320-330
Open Access | Times Cited: 1
The mechanisms of hyperglycemia and its management in new coronavirus infection
В. И. Петров, O. V. Shatalova, G. M. Glazova
Siberian Journal of Clinical and Experimental Medicine (2023) Vol. 37, Iss. 4, pp. 22-30
Open Access
Trends of the medical status of adult patients with diabetes mellitus in the Samara region for 2018—2020
N. A. Pervyshin, Р А Галкин, С. В. Булгакова, et al.
Russian Journal of Preventive Medicine (2023) Vol. 26, Iss. 5, pp. 23-23
Closed Access
Difficulties in differential diagnosis of carbohydrate metabolism disorders in patients with coronavirus infection in real clinical practice. Case report
Tatyana N. Markova, M. Stas, Valentina V. Chibisova, et al.
Consilium Medicum (2023) Vol. 25, Iss. 4, pp. 241-246
Open Access
Biological age as a risk factor for ophthalmological complications in type 2 diabetes mellitus
Н. М. Агарков, I. V. Lev, Andrey Kopylov
RESEARCH RESULTS IN BIOMEDICINE (2023) Vol. 9, Iss. 3
Open Access
Page 1

Scroll to top